Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Assets (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Return on Assets for 10 consecutive years, with 0.66% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 8.0% to 0.66% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.66% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.54% for FY2025, 5.0% down from the prior year.
  • Return on Assets hit 0.66% in Q4 2025 for Rocket Pharmaceuticals, down from 0.63% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.26% in Q1 2021 to a low of 0.66% in Q4 2025.
  • Historically, Return on Assets has averaged 0.48% across 5 years, with a median of 0.48% in 2022.
  • Biggest five-year swings in Return on Assets: rose 2bps in 2023 and later decreased -15bps in 2024.
  • Year by year, Return on Assets stood at 0.33% in 2021, then plummeted by -41bps to 0.46% in 2022, then grew by 4bps to 0.44% in 2023, then tumbled by -32bps to 0.58% in 2024, then fell by -14bps to 0.66% in 2025.
  • Business Quant data shows Return on Assets for RCKT at 0.66% in Q4 2025, 0.63% in Q3 2025, and 0.59% in Q2 2025.